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Wound Healing in the a2b1 Integrin-Deficient
Mouse: Altered Keratinocyte Biology and
Dysregulated Matrix Metalloproteinase Expression
David G. Grenache1, Zhonghua Zhang2, Laura E. Wells2, Samuel A. Santoro2, Jeffrey M. Davidson2,3 and
Mary M. Zutter2,4,5
The a2b1 integrin, a collagen/laminin receptor, is expressed at high level in the basal cell layer of the epidermis.
To define the role of the a2b1 integrin in wound healing, wound repair was extensively evaluated in wild-type
and a2-null mice in vivo. In addition, the impact of a2b1 integrin-deficiency on the function of primary murine
keratinocytes in vitro was analyzed. Our in vivo findings demonstrate that genetic deletion of the a2b1 integrin
does not significantly alter the rate of re-epithelialization, collagen deposition, or tensile strength during wound
closure in mice. In marked contrast to the observed similarities in wound healing, deletion of the a2b1 integrin
resulted in a dramatic increase in neoangiogenesis in the wound microenvironment. In contrast to in vivo
studies, primary keratinocytes from a2-null mice adhered poorly and displayed impaired migration on type I
collagen in vitro. We demonstrate that a2b1 integrin-ligation negatively regulates expression of genes including
matrix metalloproteinases both in vivo and in vitro. Furthermore, the changes in gene expression could
potentially account for relatively normal wound healing in the a2-deficient mouse and our recent observation
that suggests an antiangiogenic role for the a2b1 integrin in vivo.
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INTRODUCTION
The a2b1 integrin is the most abundantly expressed collagen
receptor on resting keratinocytes, where it is highly expressed
in the basal layer of the epidermis. The multiple members of
the b1 integrin family mediate maintenance of the epithelial
barrier, adhesion of the epidermis to the basement membrane,
epithelial migration across the dermal extracellular matrix
during development and wound healing, and signals that
maintain keratinocyte stem cells within the cell cycle for
normal self-renewal and those that stimulate epithelial
differentiation. Mice with keratinocyte-specific deletion of
the b1 integrin gene have a mild blistering disorder, partial
hair loss with diminished hair follicles, impaired epidermal
proliferation, and a mild defect in wound healing (Brakebusch
et al., 2000; Grose et al., 2002). Keratinocytes from mice with
targeted deletion of the b1 integrin gene demonstrate altered
expression of other genes including matrix metalloproteinase
10 (MMP-10; stromelysin-2), MMP-13 (collagenase-3), and
the b4 integrin subunit. Deletion of the b1 subunit results in
loss of expression of several a-b heterodimers; the contribu-
tion of individual a-b heterodimers to the changes observed in
the b1-deficient mouse have not been defined.
In vitro studies of human skin and cell lines have
suggested that the a2b1 integrin is involved in wound healing
(Saarialho-Kere et al., 1993; Dumin et al., 2001). During re-
epithelialization of a wound, keratinocytes dissolve their
hemidesmosomal attachments to the basal lamina. The a2b1
integrin is relocalized from the basal cell area and
concentrated at the forward leading edge of migrating
keratinocytes bringing the integrin in contact with type I
collagen (Martin, 1997). Keratinocyte migration on complex
matrices containing type I collagen requires the catalytic
activity of collagenase I (MMP-1). Expression of MMP-1 is
upregulated in human basal keratinocytes by the interaction
of the a2b1 integrin with type I collagen in the underlying
dermis. Keratinocyte migration on type I collagen is inhibited
by anti-MMP-1 antibodies and by inhibitory antibodies
against the a2b1 integrin (Pilcher et al., 1997).
We previously reported that wound healing occurred
normally in the a2b1 integrin-deficient mouse. In that earlier
study, a 100 mm2 full-thickness wound was placed on
the flank of wild-type and a2-null animals. Compared to
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wild-type animals, a2-deficient mice demonstrated no defect
in re-epithelialization. Both wild-type and a2-null animals
displayed a similar temporal pattern of wound closure
(Chen et al., 2002). In fact, wound closure of these
100 mm2 wounds was slightly more rapid in the absence of
the a2b1 integrin. This observation was rather surprising, as it
appeared to contradict earlier in vitro studies using inhibitory
antibodies.
To evaluate further the impact of a2b1 integrin deletion on
wound healing, the ability to repair wounded wild-type and
a2-null epidermis has now been examined more extensively
using a number of different in vivo models and primary
keratinocytes in vitro. Our in vivo findings demonstrate that
the a2b1 integrin does not play an essential role in re-
epithelialization. However, our data suggest that the a2b1
integrin plays a critical role in regulating neoangiogenesis
within the wounded microenvironment. Utilizing primary
keratinocytes from wild-type (þ /þ ) and a2-null (/) mice
to dissect the consequences of a2b1 integrin deficiency, we
now report studies describing the role of the integrin in
keratinocyte adhesion and migration, as well as gene
expression. Our in vitro findings reveal that loss of the a2b1
integrin negatively regulates the expression of a number of
genes including several MMPs.
RESULTS
Enhanced angiogenesis in the a2b1 integrin-deficient mouse
In our initial report describing the phenotype of the a2b1
integrin-deficient mouse we demonstrated that deficiency of
the a2b1 integrin failed to alter the rate of wound closure,
specifically re-epithelialization of a 100 mm2 excisional
wound. To further evaluate the impact of a2b1 integrin
deletion on wound healing, the ability to repair wild-type and
a2-null epidermis was evaluated extensively using a number
of wounding models including full-thickness 6 mm2 exci-
sional wounds, linear incisions, and subcutaneous sponge
implants placed on the flank. As shown in Figure 1a, closure
of full-thickness 6 mm2 excisional wounds proceeded at
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Figure 1. Wound closure in wild-type and a2-null mice. (a) The rate of wound closure of full-thickness 6 mm2 excisional wounds proceeded at a similar rate in
both wild-type and a2-null mice. (b) Morphologic evaluation of H&E-stained 6 mm2 excisional wounds from wild-type (þ /þ ) and a2-null (/) mice on
post-wound days 1, 3, and 6 (bar¼ 100mm) (original magnification 200). (c) Morphologic evaluation of H&E and Gomori’s trichrome stained 6 mm2
excisional wounds from wild-type (þ /þ ) and a2-null (/) mice on post-wound days 7, 14, and 21 (bar¼ 100mm) (original magnification 200).
456 Journal of Investigative Dermatology (2007), Volume 127
DG Grenache et al.
Wound Healing in a2b1 Integrin-Null Mice
a similar rate in both wild-type animals and animals lacking
the a2b1 integrin on a pure C57/Bl6 background. However,
at day 6 there was a slight but statistically significant
(P¼0.029) increase in the extent of wound closure in the
a2-null animals. These data comparing the closure of 6 mm2
excisional wounds in wild-type and a2-null animals on a
pure C57/Bl6 background confirm our previously reported
observations of the rate of closure of a 100 mm2 excisional
wound in the mixed C57/Bl6/SVJ120 animals. The slightly
increased extent of re-epithelialization in the a2-null animals
at day 6 was also similar to our previously published data. In
addition, these observations suggest that the background
studied, either C57/BL6 or mixed SVJ129/C57/Bl6, does not
affect wound closure.
Morphologic analysis of wild-type and a2b1 integrin-
deficient skin wounded by 6 mm2 excision was carried out at
multiple time points. As shown in Figure 1b, there was no
detectable morphologic difference between wild-type and
a2-null mice at 24 hours. Only mild dermal edema and
scattered inflammatory cells in the dermis were detectable in
both wild-type and a2-null animals. At day 3 a large fibrin
clot with a robust inflammatory response covered the wound
area in both genotypes (Figure 1b). The extent and composi-
tion of the immune cell infiltrate, as assessed by morphologic
evaluation of hematoxylin and eosin (H&E)-stained sections
and immunohistochemical analysis with antibodies directed
against CD45 or Gr-1 that recognize leukocytes or neutro-
phils, respectively, was similar between wild-type and
a2-null mice. By day 6, re-epithelialization was nearing
completion and the dermal matrix was beginning to
reorganize. The granulation tissue at both days 3 and 6 was
very cellular in animals of both genotypes. In contrast to these
similarities the degree of vascularization differed between
wild-type and a2-null animals. There appeared to be
increased vessel number and area in the a2b1 integrin-null
mouse.
Previous in vitro studies of the a2b1 and a1b1 integrin
collagen receptors suggested that these two integrins control
collagen deposition in the extracellular matrix and fibroblast-
mediated matrix contraction (Schiro et al., 1991; Langholz
et al., 1995; Riikonen et al., 1995; Gardner et al., 1999;
Ivaska et al., 1999; Ravanti et al., 1999). Therefore, the
dermal matrix of the wounded animals was evaluated on
days 7, 14, and 21 after wounding. As shown in Figure 1c,
there was no discernible morphological difference in the
dermal collagen when H&E and Gomori’s trichrome stained
6 mm2 excisional wounds were evaluated. Although no
detectable changes in collagen deposition were noted
morphologically, collagen fibrillogenesis was not evaluated
and our data do not exclude that there may be differences in
collagen fibrillogenesis between wild-type and a2-null mice
that are only detectable at the electron microscopic level.
Future studies will focus on collagen structure using
transmission electron microscopy. Evaluation of incisional
biopsies at the same time points also failed to identify a
difference in the dermal extracellular matrix (data not
shown).
Total collagen deposition into polyvinyl alcohol sponges,
placed beneath the skin of the back, was quantitated on days
7, 10, 14, and 21 post-implantation. As shown in Figure 2a,
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Figure 2. Neoangiogenesis but not collagen deposition nor tensile strength are altered in a2-null mice. (a) Total collagen deposition into polyvinyl
alcohol sponges on days 7, 10, 14, and 21. Data are presented as the mean and SEM (6–10 animals per genotype). (b) Tensile strain of incisional wounds
was determined at days 7, 10, 14, and 21. Data are presented as the mean and SEM (6–10 animals per genotype). (c) Immunohistochemical analysis with
anti-CD31 staining of 6 mm2 excisional wounds from day 10 after wounding wild-type (þ /þ ) and a2-null (/) animals (bar¼ 100mm) (original magnification
200). (d) Total area occupied by CD31-positive structures representing vascular area as a percentage of total dermal area (*Po0.05) on day 10 after
wounding. Data are presented as the mean and SEM (six animals per genotype).
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no differences in the amount of collagen deposition in the
sponges at days 7, 10, or 14 were observed between the wild-
type and a2-null mice. However, at day 21, the percentage of
collagen within the sponges of a2-null mice was slightly and
significantly increased (P¼0.012). In this model, the a2b1
integrin did not appear to influence collagen accumulation.
The tensile properties of a wound depend not only on the
amount of collagen, but also on the organization and
crosslinking of the matrix. The biomechanical properties of
incisional wounds were determined at days 7, 10, 14, and 21
using the parameters of tensile strength, elastic modulus,
breaking energy, and tensile stain. The parameters of tensile
strength, elastic modulus, breaking energy were not signifi-
cantly different between wild-type and a2-null mice at any
time point (data not shown). As shown in Figure 2b, there was
higher tensile strain in wounds from a2-null mice at day 14,
and a somewhat lower level in wounds of a2-null mice,
relative to wild-type animals at day 21.
To further evaluate the marked difference in neoangiogen-
esis observed in H&E-stained sections of wounded wild-type
and the a2-null skin, the area occupied by vessels within and
around the granulation tissue beneath the wounded area was
evaluated by immunohistochemical staining with anti-CD31
antibody. Anti-CD31 staining accentuated the vessels and
highlighted the marked increase in the vessel area in the
a2-null animals. As shown in Figure 2c, at day 10 after wound-
ing the vascular area was significantly increased and the
vessels appeared larger in the a2-null compared to wild-type
animals. Quantitative analysis revealed a significant 5-fold
increase in the total area occupied by vessels in a2-null mice
compared to wild-type mice at day 10 (Figure 2d). A similar
increase in vascular area was seen between days 3 and 14
(data not shown).
In summary, deficiency of the a2b1 integrin resulted in
only subtle differences in wound repair with a slightly more
rapid pace of re-epithelialization at day 6. There was no
discernible difference in collagen deposition or dermal
matrix reorganization to cause changes in tensile strength.
The major observed difference in wound healing between
wild-type and a2-null mice was the increased neoangio-
genesis in the a2-null mice.
a2b1 integrin-dependent keratinocyte adhesion
To define further the functional role of the a2b1 integrin on
keratinocytes, primary keratinocytes were isolated from wild-
type and a2b1 integrin-deficient mice. Flow cytometric
analysis of primary keratinocytes from wild-type animals
revealed high level expression of the a2b1 integrin, as shown
in Figure 3a. As expected, a2-deficient keratinocytes did not
express the integrin (Figure 3a). As the a2b1 integrin binds
preferentially to type I collagen, the ability of wild-type and
a2-deficient primary keratinocytes to adhere to either type I
collagen or fibronectin was evaluated in the absence of
serum. As expected wild-type keratinocytes adhered to type I
collagen in a Mg2þ -dependent and EDTA-inhibitable man-
ner. In contrast, a2-deficient keratinocytes failed to effectively
adhere to type I collagen in 1-hour assays (Figure 3b). Both
wild-type and a2-null keratinocytes effectively adhered to
fibronectin in a similar manner suggesting that other integrins
that mediate adhesion to fibronectin were not altered in
a2-null mice (Figure 3b).
a2b1 integrin-dependent migration
As re-epithelialization requires keratinocyte migration across
the wounded dermis, the ability of a2-deficient keratinocytes
to migrate on a monolayer of type I collagen or fibronectin
was evaluated. As primary murine keratinocytes do not
survive overnight in serum-free media used in adhesion
assays, wild-type and a2-deficient keratinocytes were cul-
tured in 10 mm cloning cylinders in keratinocyte culture
media containing 5% calcium-chelated fetal bovine serum at
a density of 1 106 cells for 24 hours. As shown above, the
a2-deficient keratinocytes did not adhere to collagen in 1 h in
the absence of serum, but a monolayer of adherent wild-type
and a2-deficient cells was generated after 24 hours using this
approach. A 1 mm scratch wound was then made across the
cell monolayer. Keratinocyte migration across the denuded
matrix was observed, photographed, and subsequently
quantitated 5, 10, and 24 hours after wounding. As shown
in Figure 4, wild-type keratinocytes migrated on both type I
collagen (Figure 4a and b) and fibronectin (Figure 4c) and
completely closed the in vitro wounds by 24 hours. In
contrast, migration of a2-null keratinocytes on type I collagen
was significantly impaired and 40% of the scratch wound
remained free of cells at 24 hours (Figure 4a and b). Migration
of a2-null keratinocytes on fibronectin was similar to that of
wild-type cells (Figure 4c). Therefore, a2-deficient keratino-
cyte migration on collagen is impaired but not completely
eliminated in the presence of low concentrations of serum. It
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Figure 3. Primary keratinocytes from wild-type and a2-null mice. (a) Flow
cytometric analysis of primary keratinocytes isolated from wild-type (þ /þ )
or a2-deficient (/) animals using a fluorescent anti-a2 integrin antibody
(open curves). The solid curves represent unlabeled control cells. (b) Adhesion
of wild-type and a2-null keratinocytes plated on type I collagen, fibronectin,
or BSA in the presence of either Mg2þ or EDTA.
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is likely that low concentrations of fibronectin and vitronectin
in the serum provide, in part, a matrix for migration for the
a2-null keratinocytes.
a2b1 integrin-independent ex vivo migration
The impaired ability of a2-deficient keratinocytes to adhere to
and migrate on type I collagen substrates in vitro suggested
that a2b1-deficient mice should have displayed a defect in
epithelial development and wound repair that was not
observed in vivo. To explore further these in vivo and in
vitro differences, 4 mm diameter punch biopsies from the
dorsal surface of wild-type or a2-deficient mice were placed
into ex vivo culture and the ability of the wild-type and a2-
deficient epidermal sheets to migrate over the exposed
dermis was evaluated. Wild-type and a2-null epithelia
migrated over the exposed dermal surface of the explanted
tissue in a similar manner (Figure 5). In addition, migration of
the epidermal sheet was not inhibited by the addition of
inhibitory antibodies directed against either the a2 or a1
integrin subunit (data not shown). These data suggest several
possibilities. One possibility is that the a2b1 integrin plays no
role in wound healing. A second more likely possibility is that
the a2b1 integrin plays a dramatically different role when
keratinocytes are exposed to a complex matrix containing
multiple collagens, laminins, fibronectin, and other matrix
components than when they are exposed to a matrix
composed predominantly of type I collagen. Third, ‘‘com-
pensatory’’ changes in gene expression that occur in the
absence of the a2b1 integrin might contribute to the normal
wound repair. We therefore evaluated the consequences of
altered a2b1 integrin expression on the expression of other
adhesion receptors and molecules required for wound repair,
such as the MMPs.
a2b1 integrin-dependent gene expression
The expression of other integrin subunits and members of the
MMP family, molecules known to be relevant to cell
adhesion, migration, and wound healing, by wild-type and
a2-deficient primary keratinocytes adherent to either type I
collagen or fibronectin for 48 hours was determined by
quantitative real-time PCR (qRT-PCR). Expression of genes by
a2-null keratinocytes relative to expression by wild-type cells
is shown in Figure 6. Expression of the a1 and b3 integrin
subunit genes and MMP-2, MMP-3, MMP-8, MMP-9, MMP-
10, MMP-13, and COLA genes was increased (greater than
2.5-fold) by a2-null keratinocytes relative to the levels of
expression exhibited by wild-type cells plated on type I
collagen (Figure 6a). Expression of the MT1-MMP gene was
increased in a2-null keratinocytes but not 2.5-fold. The
expression of the b4 integrin subunit by a2-deficient
keratinocytes was extremely variable (Figure 6a). Surpris-
ingly, expression of many genes including those encoding the
a3, a5, a6, av, b1, and b5 integrin subunits was similar when
a2-null and wild-type keratinocytes were plated on type I
collagen for 48 hours (Figure 6a). The differences in gene
expression of the integrin receptor subunits and MMPs were
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Figure 4. Migration of wild-type and a2-null keratinocytes plated on type I collagen or fibronectin. (a) Photomicrographs of wild-type and a2-null keratinocyte
scrape wounds plated on type I collagen and photographed at 0, 10, and 24 hours after wounding; (b) quantitative migration of wild-type and a2-null
keratinocytes plated on type I collagen; (c) quantitative migration of wild-type and a2-null keratinocytes plated on fibronectin.
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much less dramatic when wild-type keratinocytes and a2-null
keratinocytes were plated on fibronectin (Figure 6b). The
increased levels of MMP-8 messenger RNA and the slightly
increased levels of MMP-3 and McolA demonstrated by a2-
null keratinocytes cultured on collagen were also observed
when the cells were cultured on fibronectin. However, the
relative increase in these two MMPs was less pronounced
than that observed when the cells were plated on collagen.
The only gene evaluated whose expression was slightly
diminished by the absence of the a2b1 integrin when
keratinocytes were cultured on either collagen or fibronectin
was the b4 integrin subunit. In fact, expression of the b4
integrin subunit by a2-deficient keratinocytes was decreased
relative to expression by wild-type keratinocytes plated
on either type I collagen or fibronectin. In large part, the
changes in gene expression observed in the absence of
the a2b1 integrin were ligation-dependent and resulted from
the interaction, or lack thereof, of the a2b1 integrin with
type I collagen. In contrast, diminished expression of the
b4 integrin subunit gene was independent of integrin
ligation.
Changes in the expression of messenger RNA in cells and
tissues may or may not be reflected by altered protein
expression. Therefore, the changes detected by qRT-PCR
were evaluated by Western blot analysis when antibodies
were available. As shown in Figure 6c, expression levels of
MMP-9 were increased 2-fold or greater when either wild-
type or a2-null keratinocytes were plated on type I collagen
in comparison to fibronectin. In addition, a2-null keratino-
cytes expressed slightly higher levels of MMP-9 than wild-
type keratinocytes when plated on type I collagen. Expression
+/+ –/–
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Figure 5. Migration of epidermal keratinocytes over the dermal edge of
explanted skin obtained from wild-type and a2-null mice. The arrows
indicate the location of the leading edge of keratinocytes at 0, 24, 48, and
72 hours (bar¼ 100 mm) (original magnification  200).
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Figure 6. Altered gene expression in a2-null keratinocytes. Gene expression
determined by qRT-PCR using RNA from wild-type and a2-null keratinocytes
plated on either (a) type I collagen or (b) fibronectin. Bars represent transcript
expression in a2-null cells relative to wild-type cells and normalized to
expression of a glyceraldehyde-3-phosphate dehydrogenase control gene.
Results are the averages of three separate experiments. (c) Protein expression
and activity of MMP-2 and MMP-9 determined by immunoblot analysis and
gelatin zymography and protein expression of MMP-8 determined by
immunoblot analysis.
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of MMP-2 was slightly increased by both wild-type and
a2-deficient keratinocytes keratinocytes plated on collagen
but not on fibronectin. There were no detectable differences
in MMP-2 expression between wild-type and a2-deficient
keratinocytes. The expression of MMP-8 was more variable
(Figure 6d). MMP-8 was expressed at higher levels by wild-
type keratinocytes plated on fibronectin and by a2-null
keratinocytes plated on collagen. The a2-null cells expressed
lower levels of MMP-8 when plated on fibronectin. To assess
the activity of MMP-2 and MMP-9 gelatin zymography was
performed (Figure 6e). Zymography confirmed the increased
expression of MMP-9 when a2-deficient keratinocytes were
plated on collagen in comparison to wild-type cells plated on
collagen or either wild-type or a2-deficient keratinocytes
plated on fibronectin. MMP-2 was only detected at extremely
low levels by gelatin zymography.
Gene expression in wounded tissue
The marked discordance in the role of the a2b1 integrin in
keratinocyte adhesion and migration in vitro on defined
substrates versus in vivo on a complex matrix suggested
either that changes in gene expression were more a
consequence of the in vitro culture conditions or that the
alterations in gene expression by a2-null keratinocytes
compensated for the lack of the integrin and allowed normal
wound healing to proceed. To evaluate these two alter-
natives, expression of several genes that were altered in vitro
was determined in wounded tissue in vivo. Biopsies were
harvested from wounded animals at various time points after
the induction of a wound and gene expression was evaluated
by qRT-PCR (Figure 7). In the resting, uninjured skin,
(time¼0), the expression of the a1 integrin subunit was
slightly elevated and the expression of the b4 subunit was
diminished in the a2-null versus the wild-type mouse.
Expression of all other integrin subunits and the MMP’s was
similar in the unwounded wild-type and the a2-null skin.
In contrast to the expression in uninjured skin, the
temporal changes in gene expression following injury were
different in the wild-type and a2-null mouse and resembled
the differences in expression observed in primary keratino-
cytes plated on type I collagen. Expression of MMP-2, MMP-
9, MMP-10, and MMP-13 messenger RNA from biopsies of
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a2-null and wild-type wounded skin increased in a time-
dependent manner with a peak occurring between days 3
and 6, as shown in Figure 7. Following the peak there was
a gradual decline to baseline levels by day 12, except for
MMP-2. Increased expression for all MMPs was relatively
greater in the a2-null than in the wild-type wounds. Although
expression of the a1 integrin subunit was greater in
unwounded a2-null than wild-type skin, the difference in
a1 integrin subunit expression was no longer evident after
wounding.
MMP-2 messenger RNA was increased in both genotypes
by post-wound day 6. Expression of MMP-2 was 1.7 times
greater on post-wound day 6 and 1.6 times higher on post-
wound day 12 in a2-null mice compared to wild-type
animals. MMP-2 levels did not taper by day 12 in wounds
from either genotype. MMP-9 expression was maximal
between post-wound days 3 and 6 in wild-type animals and
gradually declined to near baseline levels by post-wound day
12. In the a2-null mouse, MMP-9 expression reached a peak
2.2 times higher than that observed for wild-type animals on
post-wound day 6. MMP-9 expression returned to near
baseline levels by post-wound day 12. Similarly, expression
of MMP-10 and MMP-13 peaked between post-wound days
6–9 in both genotypes; on day 6, expression of MMP-10 was
2.9 times, and MMP-13 was 2.3 times higher in a2-null than
wild-type wounds. MMP-3 messenger RNA levels were higher
in the a2-null mouse wound only on day 6 after wounding.
No differences were noted in the levels of expression of the
b3 integrin subunit, MMP-8, MT1-MMP, and COLA.
DISCUSSION
In our earlier report we presented initial data that lack of the
a2b1 integrin does not alter normal epithelial development
and differentiation, nor does it affect the rate of re-
epithelialization of a 100 mm2 excision. In this report we
now compare multiple parameters of wound healing in wild-
type and a2b1 integrin-deficient mice. In fact, genetic
deletion of the a2b1 integrin does not alter the rate of re-
epithelialization, the inflammatory component of granulation
tissue, the quantity of collagen deposited within the wound,
or the tensile strength of the wound in the murine model. In
contrast to the many similarities between the wild-type and
the a2-null animals, deletion of the a2b1 integrin resulted in a
dramatic increase in neoangiogenesis in the wounded
environment.
In contrast to the dispensable role of the a2b1 integrin
expression plays in re-epithelialization in vivo, we observed
that a2-deficient primary keratinocytes adhere poorly to type
I collagen in vitro and display impaired migration across type
I collagen substrates. The inability to migrate on type I
collagen is consistent with earlier reports by other investiga-
tors demonstrating that the a2b1 integrin regulates expression
and localization of MMP-1 at the migration front during
wound healing of human epithelium (Pilcher et al., 1997).
Although a2-null keratinocytes were unable to migrate
effectively across a type I collagen matrix in vitro, they were
able to migrate over the complex and heterogeneous matrix
of the dermis in ex vivo experiments. Collectively these data
suggest that in vivo wound healing in mice is not dependent
on the interaction between the a2b1 integrin and collagen.
The changes in gene expression that occur downstream of
a2b1 integrin expression and/or ligation suggest that a2b1
integrin expression is a determinant of the expression of
numerous genes of the MMP and integrin families, as well as
other genes contributing to extracellular matrix composition
and remodeling. Specifically, greater than 2.5-fold increases
in the expression of the a1 and b3 integrin subunits and
MMP-2, MMP-9, MMP-10, and MMP-13 were observed
when a2-null versus wild-type keratinocytes were plated on
type I collagen. Lesser increases in expression of the same
molecules were observed in a2-null keratinocytes cultured on
fibronectin, suggesting that both expression and subsequent
ligation of the a2b1 integrin by collagen contributed to the
observed differences. On the other hand, expression of MMP-
3, MMP-8, and COLA was upregulated greater than 2.5-fold
by a2-null cells on either substrate. The absence of the a2b1
integrin may remove a signaling pathway that suppresses
these substrate-independent target genes. However, a more
likely possibility is that the compensatory amplification of
other matrix signaling pathways led to higher expression of
these three target genes. Furthermore, the observed changes
in gene expression of matrix molecules, adhesion receptors,
and MMPs that occur as a consequence of the loss of
expression of the a2b1 integrin and/or ligation of the a2b1
integrin suggest that these changes may contribute to the
normal wound healing observed in the a2b1 integrin-
deficient mouse. The changes in gene expression were
observed not only in cell culture models but also temporally
during wound repair in vivo.
The marked increased in neoangiogenesis in the wound-
ing environment is intriguing. The results reported in this
manuscript provide evidence that lack of a2b1 integrin does
not effect developmental angiogenesis but has a significant
effect on pathologic angiogenesis in other microenviron-
ments including wound healing.
The correlation between lack of a2b1 integrin expression
and increased expression of several MMPs suggests that a2b1
integrin expression and/or ligation may negatively regulate
the levels of specific MMPs. This correlation provides another
potential mechanism by which the a2b1 integrin may
regulate angiogenesis. MMP expression, particularly MMP-2
and MMP-9 are essential for angiogenesis. In addition to gene
expression, MMP-9 protein was only detected in keratino-
cytes plated on collagen, but not on fibronectin. There is low-
level MMP-9 activity by wild-type keratincytes plated on
collagen, but significant activity by a2-null keratinocytes. The
difference in MMP-9 activity between wild-type and a2-null
cells is intriguing and suggests that other, as yet unidentified
factors controlled by the integrin play a role in regulating
activity. Alternatively, loss of the a2b1 integrin may result in
the loss of modulation of positive signals from other integrins
such as the avb3 and a5b1 integrins. Markedly reduced
or absent expression of the a2b1 integrin is observed in
poorly differentiated carcinomas during tumor progression
(Pignatelli et al., 1990, 1991, 1992; Zutter et al., 1990, 1993;
Koukoulis et al., 1991). Our findings suggest that loss of the
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a2b1 integrin may be a determinant of the increased MMP
expression associated with tumor progression and neoangio-
genesis, invasion, and metastasis.
Many of the changes in keratinocytes observed in the a2-
null mouse were also observed in mice with targeted deletion
of the b1 integrin, suggesting that several of the defects
observed in the b1 integrin-targeted mice are a consequence
of the loss of the a2b1 integrin. Both a2-null and b1-null
keratinocytes demonstrated poor adhesion to collagens and
diminished cell migration. The alterations in the expression of
several genes regulated during wound healing, including
MMP-10 and MMP-13, were observed in wounded tissue
from both the a2-null and b1-null mice (Grose et al., 2002).
However, other defects observed in the b1-null mouse were
not apparent in the a2-null mouse. For example, wound
healing was severely impaired owing to failure of re-
epithelialization in the b1-null mouse, but not in the a2-null
mouse indicating that a subunits other than the a2 integrin
subunit were responsible for the wounding defect observed in
the absence of the b1 integrin. The most dramatic difference
in MMP expression between wild-type and a2-null mice
in vivo was noted for MMP-3, or stromelysin, 6 days after
wounding. MMP-3 is known to be upregulated within
24 hours in the wounded microenvironment. Expression of
MMP-3 in non-malignant tissue is primarily by stromal cells,
and not by the epithelial cells. Although deletion of MMP-3
had a no impact on reepithelization, the MMP-3-null mice
healed more slowly and failed to contract their wounds
(Bullard et al., 1999). One could postulate that the relatively
normal wound closure observed in the a2-null mouse could
be due to compensatory upregulation of MMP-3.
A decrease in the b4 integrin subunit was observed in both
the a2-null mouse and the b1-null mouse. In the b1-null
epidermis, the hemidesmsomal disruption with disorganized
b4 integrin localization along the basal cell layer suggested
decreased levels of b4 integrin expression. In the a2-null
mouse, the level of b4 integrin expression was dramatically
decreased in primary keratinocytes and in the wounded and
unwounded skin of the a2-null animals. The decreased
expression of the b4 integrin subunit in a2-null keratinocytes
is consistent with our earlier in vitro studies of a poorly
differentiated murine mammary carcinoma cell line (Sun
et al., 1998). In these earlier studies, re-expression of the
a2b1 integrin restored epithelial differentiation that was
accompanied by increased a6b4 integrin expression. The
present studies as well as our earlier studies indicate that
a2b1 integrin expression is an important determinant of a6b4
integrin expression. It is noteworthy that neither the a2-null
nor the b1-null mouse exhibited the severe blistering disorder
exhibited by the a6b4-null and the a6-null mice (Dowling
et al., 1996; Georges-Labouesse et al., 1996; van der Neut
et al., 1996). These findings suggest that the reduced level
of the a6b4 integrin exhibited by either the a2-null or the
b1-null mice is sufficient to prevent the blistering phenotype.
In summary, although wound healing is remarkably
normal in the absence of a2b1 integrin expression, mice
lacking a2b1 integrin expression exhibit increased angio-
genesis in the wounding microenvironment. It now appears
that neoangiogenesis stimulated by not only the tumor micro-
environment, but in addition wounding, is regulated in part
by a2b1 integrin expression. Although a2-deficient primary
keratinocytes adhered poorly to type I collagen in vitro and
displayed impaired migration across a matrix of type I
collagen in vitro, a2-null keratinocytes are able to migrate
over the heterogeneous and complex matrix that is contained
within the dermis as shown in the ex vivo migration data
reported here. Our data from the murine model suggest that
in vivo wound healing does not require the a2b1 integrin. In
addition, the changes in gene expression suggested that other
matrix molecules, other receptors and the upregulation of
MMP’s could potentially account for normal wound healing
in the a2-null mouse. In vitro studies of human skin have
suggested that the a2b1 integrin is required for wound
healing (Koukoulis et al., 1991; Pignatelli et al., 1992).
Inhibitory antibodies against the a2b1 integrin prevent
keratinocyte migration on type I collagen and across
wounded dermis and block fibroblast contraction of three-
dimensional collagen gels (Koukoulis et al., 1991; Pignatelli
et al., 1992). However, deficiency of the a2b1 integrin failed
to alter wound healing in vivo and had no effect on the
migration of keratinocytes over exposed dermis suggesting
that a2b1 integrin does not play an obligatory role in wound
healing. There are several possible explanations for the
discrepancy between the deletion of the gene and antibody
inhibition studies with human cells. One arises from the use
of two different organisms that may not be mechanistically
equivalent as model systems. In contrast to murine skin,
which is rich in loose connective tissue, the human dermis is
composed of dense fibrillar collagens. As human keratino-
cytes must migrate across a collagen-rich substratum, perhaps
the human a2b1 integrin has evolved additional functions not
required in the murine models. In addition, specific MMPs
and their matrix specificity differ between humans and mice.
In the human MMP-1 is expressed by keratinocytes at the
migrating front of the epithelial sheet during wound closures.
In mice, MMP-13 is expressed by the same cell population,
but, MMP-13 and MMP-1 have distinct substrate specificities
and distinct functions. Therefore, the difference between not
only the integrin, but the matrix and the MMP specificity may
explain the dramatic differences between the importance of
the a2b1 integrin in humans and mice. Second, on binding
the integrin, inhibitory antibodies may stimulate signals
downstream of the integrin that are responsible for the
observed phenotype. Thus, antibodies could produce effects
that differ from those because of lack of integrin expression.
Finally, the major impact on wound healing that results from
deleting the a2b1 integrin is on neoangiogenesis. The results
suggest that the integrin controls neoangiogenesis in a
number of models including wound healing and within the
tumor microenvironment.
MATERIALS AND METHODS
Mice
The development of mice with complete genetic deletion of the a2
integrin subunit gene was previously described (Chen et al., 2002).
a2 Integrin subunit-deficient mice were backcrossed 10 times onto
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the C57/Bl6 background to obtain animals that were 99%
genetically C57/Bl6. The animals were housed in pathogen-free
conditions at Vanderbilt University Medical Center, in compliance
with IACUC regulations. Animals were used at 6–12 weeks of age.
Within individual experiments, mice were appropriately age and sex
matched.
In vivo wounding and tissue preparation
Six- to 12-week-old wild-type and a2-null animals were anesthe-
tized with a 0.1 ml intraperitoneal injection of ketamine (17.4 mg/ml)
and xylazine (2.6 mg/ml). The dorsal surface of the animal was
shaved and sterilized. Full-thickness wounds were made in the flank
using a disposable, sterile, 6-mm punch biopsy (Miltex Instruments,
Bethpage, NY). Animals were housed in individual cages with a wire
grating placed above the bedding to prevent it from becoming
embedded in the wounds. For quantitation, photographic wound
closure data were collected using a Coolpix 5000 digital camera
(Nikon, Tokyo, Japan) and wound area was measured using Image-
Pro Software (Mediacybernetics Inc., Silver Spring, MD). Closure
area was quantified against a scale bar photo label in each image.
Means per group and SEM were calculated and graphed. Wounds
were allowed to heal for varying lengths of time at which point
animals were killed and the wounds completely excised. The
excised wounds were immediately homogenized in Trizol (Life
Technologies, Rockville, MD) for isolation of total RNA.
Histology, immunohistochemistry, and immunofluorescence
analyses
Morphology of the wounds was initially evaluated on paraffin-
embedded, H&E, or Gomori’s trichrome-stained sections. Immuno-
histochemical analyses were carried out on 6mm frozen-sections,
fixed briefly in acetone, and stained with the rat anti-CD31 antibody
(BD Biosciences, Pharmingen, San Diego, CA) at a 1:100 dilution.
The signal was detected with biotinylated goat-antirat IgG and
avidin-biotin complex reagent, the VECTASTAIN Elite ABC Kit
(Vector Labs, Burlingame, CA). The slides were examined and
photographed using a Nikon 80i manual system microscope with
motorized shutter for digital imaging and images were processed with
Metamorph imaging system (Molecular Devices, Sunnyvale, CA).
Wound analysis
Collagen content of wounds was determined from the acid-
hydrolyzed homogenate of a segment of each implanted polyvinyl
alcohol sponge. Amino-acid analysis of the derivatized hydrolysate
yielded hydroxyproline and other amino acids to estimate both total
and relative collagen content (Buckley et al., 1988). Mechanical
testing of incisional wounds was accomplished by analysis of tissue
strips that were excised post mortem to include a transverse segment
of a 1 cm linear incision. After storage at 201C within saline-
moistened gauze in an air-tight wrapping, skin strips were thawed
and tested while moistened in an Instron biomechanical testing
device, using three preconditioning cycles and an elongation rate of
1 mm/s. BluehillTM software was used to collect data on tensile
strength, elastic modulus, breaking energy, and tensile stress.
Primary keratinocyte isolation, culture, and characterization
Primary keratinocytes were isolated from the skin of neonatal mice
as described previously (Yuspa et al., 1980). Skin from the torso of
one to 2-day old mice was exposed to 0.25% trypsin in Hank’s-
buffered saline solution overnight at 41C. The epidermis was
removed as a sheet, minced, and then agitated at 371C for
45 minutes in 10 ml of keratinocyte growth media. The minced
epidermis was filtered through a 70 mm cell strainer (BD Biosciences
Discovery Labware, Bedford, MA) to remove the stratum corneum.
Cells were pelleted by centrifugation and resuspended in fresh
keratinocyte growth media for experiments. Keratinocyte growth
media was composed of Minimum Essential Medium modified
for suspension cultures (Invitrogen, Carlsbad, CA) supplemented
with 5% calcium-chelated fetal bovine serum (HyClone, Logan, UT),
0.05 mM CaCl2, 4 mM glutamine (Invitrogen), 5mg/ml insulin
(Sigma-Aldrich, St Louis, MO), 10 ng/ml epidermal growth factor
(Invitrogen), 0.4mg/ml hydrocortisone (Sigma-Aldrich), 1010 M
cholera toxin (Sigma-Aldrich), 2 109 M triiodothyronine (Sigma-
Aldrich), 100 IU/ml penicillin, and 100 mg/ml streptomycin (Invitro-
gen). Chelated fetal bovine serum was prepared using Chelex-100
resin (Bio-Rad Laboratories, Hercules, CA) in accordance with the
manufacturer’s instructions.
Flow cytometric analysis was performed on freshly isolated cells
harvested with 2 mmol/l EDTA in phosphate-buffered saline (pH
7.45). Single cells (1 106) in phosphate-buffered saline containing
1.5% horse serum were incubated with fluorescein-conjugated anti-
murine a2 integrin antibodies (Pharmingen, San Diego, CA) for
45 minutes at 41C. Cells were washed three times, resuspended in
phosphate-buffered saline, and analyzed using a FACScan instru-
ment (Becton Dickinson, Mountain View, CA).
Adhesion assays
Primary keratinocytes were resuspended in Hank’s-buffered saline
solution with either 2 mM MgCl2 or 2 mM of EDTA and plated at a
density of 2 105 cells into wells of a 96-well plate coated with
either 25 mg/ml type I collagen (BD Biosciences Discovery Labware),
50 mg/ml fibronectin (Sigma-Aldrich), or 0.5% BSA (Sigma-Aldrich)
and allowed to adhere for 1 h at 371C. Non-adherent cells were
removed by washing and adhesion was quantitated by spectro-
photometric measurement of p-nitrophenol produced by enzymatic
conversion from p-nitrophenol N-acetyl-b-D-glucosaminide by
cellular b-hexosaminidase (Santoro et al., 1994).
Cell migration analysis in vitro
Primary keratinocytes resuspended in keratinocyte growth media
were plated at a density of 1 106 cells into 10 mm cloning
cylinders (Bellco Glass, Vineland, NJ) that had been placed on six-
well non-tissue culture treated cluster dishes coated with either
100mg/ml of type I collagen or 50 mg/ml of fibronectin and allowed
to adhere for 24 hours at 371C. Cloning cylinders were removed,
2 ml of keratinocyte growth media were added, and 1 mm wide
scrape wounds were made across the cell monolayer using a
disposable pipette tip. Scrape wounds were photographed at 0, 5,
10, 24 hours, and migration was digitally quantitated (Scion Image
software, Scion Corp, Frederick, MD) by measuring the surface area
of the wound that remained free of adherent cells at each time point.
Cell migration analysis ex vivo
Six- to 8-week-old wild-type and a2-null animals were euthanized
and the dorsal skin shaved, excised, and cleaned by brief,
consecutive washes in 70% ethanol, Betadine, and sterile water.
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Punch biopsies (4 mm) were removed and placed dermis side down
in wells of an 18-well cluster dish. Explants were allowed to adhere
for 5 minutes before adding culture medium (DMEM, Invitrogen)
supplemented with 5% fetal bovine serum, 100 U/ml penicillin, and
100mg/ml streptomycin) in sufficient volume to just cover the
epidermis of the explanted tissue. Explants were incubated at 371C
for up to 72 hours and media was replaced every 24 hours. Anti-a2
integrin subunit and anti-a1 integrin subunit inhibitory antibodies
(BD Biosciences Pharmingen, San Diego, CA) (10 mg/ml) were
added. The quantitation of epithelial tongue migration was carried
out by photographing the slides and measuring the distance from the
cut margin.
RNA isolation
Total RNA from primary keratinocytes cultured on Petri dishes
coated with either 100 mg/ml of type I collagen or 50 mg/ml of
fibronectin for 48 hours was isolated using the RNeasy RNA isolation
system (Qiagen, Valencia, CA) and following the manufacturer’s
recommendations. Total RNA from full-thickness skin wounds was
isolated from samples homogenized in Trizol following the
manufacturer’s recommendations followed by processing using the
RNeasy RNA isolation system as described above.
QRT-PCR analysis
Total RNA isolated from primary keratinocytes or wound tissue was
treated with DNase and reverse transcribed to single-stranded cDNA
using Superscript II (Life Technologies) with an oligo-dT primer. A
single primer/probe set for each gene of interest was designed and is
shown in Table 1. QRT-PCR was performed with a Bio-Rad iCycler
(Bio-Rad, Hercules, CA) and the SYBR green reporter dye (Applied
Biosystems, Foster City, CA). Each assay included a negative control
using RNA not subjected to reverse transcription. Expression of each
gene was normalized to the expression of glyceraldehyde-3-
phosphate dehydrogenase.
Immunoblot analysis
Keratinocytes were lysed in lysis buffer (50 mmol/l N-2-hydro-
xyethylpiperazine-N0-2-ethanesulphonic acid, (pH 7.2), 250 mmol/l
NaCl, 2 mmol/l EDTA, 0.1% Nonidet P-40, 10 mg/ml aprotinin, 5mg/
ml leupeptin, 40 mmol/l NaF, 0.5 mmol/l phenylmethyl sulfonyl
fluoride, 0.5 mmol/l o-vanadate, and 1 mmol/l dithiothreitol). Total
protein concentration was determined by the Pierce protein assay
(Fisher Scientific, Pittsburgh, PA). Equivalent amounts of protein
lysate were subjected to SDS-PAGE and electroblotted onto
Immobilon-P transfer membrane (Fisher Scientific). Immunoblots
were incubated overnight with the appropriate dilution of primary
antibody at 41C followed by secondary horseradish peroxidase-
conjugated sheep anti-mouse or anti-rabbit antibody (Amersham
Pharmacia Biotech, Piscataway, NJ) for 1 hour at room temperature.
Primary antibodies used included anti-murine MMP-2 (Clone
42-5011, Oncogene Inc., Cambridge, MA), MMP-8 (Biomol Inc.,
Plymouth Meeting, PA) and MMP-9 (Oncogene Inc., Cambridge,
MA). Enhanced chemiluminescence system (Amersham Pharmacia
Biotech) was used for visualization.
Zymography
Gelatin zymography was performed on cells lysed in Laemmli’s
sample buffer. Total protein concentration was determined as
described above. One hundred micrograms of total protein was
loaded on 10% SDS-polyacrylamide gels containing 0.1 mg/ml
gelatin and run at 100 V for 4 hours in non-reducing conditions. After
electrophoresis, gels were washed with 2.5% Triton X-100 twice for
Table 1. Primer sequences used in qRT-PCR analysis
mRNA Forward primer Reverse primer
a1 CACCTTTCAAACTGAGCCCGCCA GCTGCCCAGCGATGTAGAGCACAT
a3 TGGGCAAGTGCTATGTGCGTGGCA TCTGGGTGAAGCCGCCGCTGGT
a5 CACTTGGCTTCAGGGCATTTC CAACTACACCCCCAACTCACAGG
a6 CTGGCTTCCTCGTTTGGCTATG TGCCTTGCTGGTTAATGTAGACGT
av TTGGGGACGACAACCCTCTGACAC TGCGGCGGGATAGAAACGATGAG
b1 TCTCACCAAAGTAGAAAGCAGGGA ACGATAGCTTCATTGTTGCCATTC
b3 GCTTTGGGGCCTTCGTGGACAA CATGGGCAAGCAGGCATTCTTCAT
b4 CACCCACCAGGAAGTACCCAGT GACCAGTCCATAGCAGACCTCGTA
b5 ACGACCGCCGAGAGTTTGCCAA GCCATCCAGGAGCCTCAGTCCAC
MMP-2 TATGGATTCTGCCCCGAGACC ACACCACACCTTGCCATCGTT
MMP-3 TCTGGGCTATACGAGGGCACGAGG TGGCAGCATCGATCTTCTTCACGG
MMP-8 AGCCTGTGACCCCCACCTGAGATT GGCCGGGCCAGAACAGAGATATG
MMP-9 TCTCGGGAAGGCTCTGCTGTT TTGGTACTGGGAGATGTCGTGTGA
MMP-10 CTCCAAGACCTGAGACCCCAGACAA TCCAATGGGATCTGCGCCAGA
MMP-13 CTGAGCGCTGCGGTTCACTTTGAG TGAGGCGGGGATAATCTTTGTCCA
MT1-MMP CTGAGGGTTTCCACGGCGACAGTA TCCAGGGCTCGGCAGAATCAAAGT
COLA GGCAAATGCAGCAGTTATTTGGGC ATGGGGCCACATCAGGCACCC
MMP, matrix metalloproteinase; qRT-PCR, quantitative real-time PCR.
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15 minutes and incubated at 371C in substrate buffer (50 mmol/l Tris-
HCl (pH 7.5), 10 mmol/l CaCl2) overnight. Gels were stained with
0.5% Coomassie blue, 50% methanol, and 10% acetic acid and
destained in 50% methanol, 10% acetic acid. Bands were quantified
by densitometry using an Alpha Imager 2000 (Alpha Innotech, San
Leandro, CA).
Statistical analysis
Statistical analysis was performed using either analysis of variance or
unpaired Student’s t-test and Po0.05 was considered statistically
significant. All calculations and graphs were performed using
GraphPad Prism Version 4 (GraphPad Software, San Diego, CA).
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